Developer docs
API playgroundTry for free, no card

Search company profiles

Gsap

Full company profile

uuid000wdb3

Namestring
Gsap
Legal namestring
Gsap
Websiteurl
gsap.co.il
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Gsap is an Israeli professional services consulting firm headquartered in Haifa, founded in 2009, that provides end-to-end regulatory, quality, clinical, and engineering services to biomedical and life-science companies across seven industry verticals: medical devices, pharmaceuticals and biotechnology, advanced therapies (cell and gene), medical cannabis, digital health, food tech, and hospitals. The firm delivers regulatory strategy and submissions to FDA, EMA, and the Israeli Ministry of Health; quality management system setup and audit preparation; Contract Research Organization (CRO) services for Phase I-II clinical trials; engineering validation and qualification (IQ/OQ/PQ); and computerized systems validation (CSV). Core service lines are organized around recognized frameworks including GxP, GEP, GMP, ISO 13485, MDSAP, IEC 62304, ICH-GCP, and ISO 14155.

The business operates through four wholly-owned subsidiaries that extend its offering beyond consulting hours: SE-Pharma (GDP compliance and ISO/IEC 17025:2017 accredited laboratory services, est. 2016), Gsap CRO (boutique Phase I-II clinical trial management, est. 2017), Almond (electronic Quality Management System software platform, est. 2018), and G-Study (professional training, auditor certification, and the PractiClean conference, est. 2020). Revenue is generated through project-based professional services engagements, training course fees, and the Almond QMS software product, sold via direct consultative sales to enterprise clients including startups, pharma companies, hospitals, and medical device manufacturers. The firm employs approximately 60 staff at the parent plus 15 across subsidiaries, and reports cumulative engagement of 2,000+ projects, 300+ medical device clients (since 2014), and 40+ advanced therapy clients (since 2012), with notable customer engagements including Johnson & Johnson's Biosense Webster, Philips Haifa, Pluristem, Sheba Medical Center, Hadassah Medical Center, the Israel Institute for Biological Research (IIBR), and Syqe Medical.

Gsap is privately held with no external funding rounds disclosed and operates under a management-owned structure following the founding-era transition from founder Dr. Sigalit Ariely-Portnoy to current CEO Sharon Alon. Distribution is primarily direct enterprise sales complemented by content marketing, webinars, the PractiClean conference, and the Gstudy training platform, with geographic reach spanning the US, Europe (Germany, Netherlands), and the broader Israeli biomedical ecosystem.

Short descriptiontext

Gsap is an Israeli biomedical consulting firm providing regulatory affairs, quality assurance, CRO clinical research, engineering validation, and electronic QMS software to medical device, pharma, advanced therapy, digital health, medical cannabis, food tech, and hospital clients globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHaifa, Israel
HQ citystring
Haifa
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory affairs consulting, quality assurance services, biomedical consulting, GMP compliance consulting, clinical research services
Industry4 codes
PRIMARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAG
Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAOAK
CMC, Process Development & Tech Transfer Staffing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code2 codes
  • Management Consulting Services54161
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Biomedical Regulatory & Quality Consulting
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Regulatory Affairs & Quality Consulting
TypeProfessional Services
Description

Gsap charges fees for regulatory strategy, submissions (FDA, EMA, IMOH), quality management system setup, and compliance consulting. Revenue is project-based and varies by scope, typically structured as professional services engagements.

gsap.co.il
2CRO — Clinical Research Services
TypeProfessional Services
Description

Full-service clinical trial management including study design, site management, monitoring, data management, biostatistics, and clinical study reports. Revenue is generated through project fees and service contracts following ICH-GCP standards.

gsap.co.il
3Gstudy — Professional Training Courses
TypeProfessional Services
Description

Gsap operates Gstudy, a training center offering professional courses, seminars, auditor certification programs, and webinars. Revenue is generated through course fees.

gsap.co.il
4Engineering & Validation Services
TypeProfessional Services
Description

Charges for engineering validation, qualification (IQ/OQ/PQ), facility design review, and GMP compliance services for pharmaceutical and medical device manufacturing facilities.

gsap.co.il
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1G-Study (Gstudy)
Description

Training and learning center offering professional courses, seminars, auditor certification, internal organizational training, online courses, and webinars for the pharma, advanced therapies, medical devices, and medical cannabis industries.

gsap.co.il
+3 more records
Core offering1 text field

Gsap is a professional consulting firm providing end-to-end biomedical services spanning the entire product lifecycle — from concept to market — for pharmaceutical, medical device, advanced therapy, digital health, food tech, medical cannabis, and hospital clients. Core service lines include regulatory affairs (FDA, EMA, IMOH submissions), quality assurance and QMS setup, clinical research (CRO) trial management, engineering validation (GEP/GMP), computerized systems validation (CSV), pre-clinical studies, audit preparation, and grant writing. The firm supplements consulting with its Gstudy training academy and Almond electronic QMS platform, all delivered by 50+ expert consultants from its Haifa, Israel headquarters.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 2000+ projects completed across biomedical consulting portfolio
+5 more records
Product overview1 text field

Gsap is a comprehensive consulting and services firm for the biomedical industry, providing end-to-end services across the product lifecycle. The portfolio consists of core consulting service lines — Regulatory Affairs, Quality Assurance (QMS), Clinical Research (CRO), Engineering & Validation, Computerized System Validation (CSV), Pre-Clinical Studies, Grant & Technical Writing, and Audit Preparation — organized by specialized industry verticals: Pharmaceuticals, Medical Devices, Digital Health, Advanced Therapies (ATMP), FoodTech, Medical Cannabis, and Hospitals. The company operates two named sub-brands: Gsap CRO (a boutique CRO for clinical trial management under ICH-GCP) and Gstudy (a professional training and education center). Gsap's services are not packaged as a single software product but as professional consulting engagements delivered by domain experts.

Product and service11 records
1Regulatory Affairs Consulting
CategoryRegulatory Affairs Consulting
Description

End-to-end regulatory strategy and submission services for biomedical products targeting FDA, EMA, Israeli Ministry of Health (IMOH/AMAR), Health Canada, and TGA, covering pre-IND/IND, NDA, BLA, MAA, 510(k), CE marking, and ATMP regulatory pathways for pharma, medical device, advanced therapy, digital health, food tech, and medical cannabis clients.

2Quality Assurance (QMS) Consulting
3Gsap CRO - Clinical Research Services
CategoryClinical Research / CRO Services
Description

Full-service Contract Research Organization providing clinical trial management from study design, regulatory submissions, site selection, monitoring, data management, biostatistics, and clinical study reports, following ISO 14155 and ICH-GCP standards for medical device, pharmaceutical, and advanced therapy trials.

4Engineering & Validation Services
5Computerized Systems Validation (CSV)
6Pre-Clinical Studies
7Audit Preparation & Inspection Support
8Grant & Technical Writing
9Gstudy - Professional Training Programs
CategoryProfessional Training & Education
Description

Professional training center offering courses, seminars, auditor certification programs, and webinars for pharma, medical device, advanced therapy, and medical cannabis industries. Courses are delivered both in-person at the Haifa training center and online in hybrid format; in-house corporate training programs are also available.

10Almond - Electronic Quality Management System (QMS)
CategoryQuality Management Software
Description

Electronic Quality Management System (QMS) software platform (Almond II being the next-generation product) for biomedical companies, supporting document control, CAPA management, complaint handling, and quality process workflows.

11SE-Pharma - GDP Compliance Services
CategoryGDP Compliance & Laboratory Services
Description

Good Distribution Practice (GDP) compliance consulting, Ministry of Health Procedure 126 implementation, and ISO/IEC 17025:2017 accredited laboratory services for pharmaceutical distributors and biomedical companies.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1SE-Pharma
Strategic tierCoreTypeOthers
Description

SE-Pharma is a wholly-owned subsidiary of Gsap, established in 2016 to support Gsap clients in implementing GDP requirements and Israeli Ministry of Health Procedure 126. The company is accredited to ISO/IEC 17025:2017 standards.

gsap.co.il
Strategic tierCoreTypeOthers
Description

Almond is a wholly-owned subsidiary of Gsap, established in 2018 to provide an electronic Quality Management System (QMS) at world-class level to biomedical companies in Israel and globally. Almond II represents the next-generation QMS platform.

3G-Study
Strategic tierCoreTypeOthers
Description

G-Study is a wholly-owned subsidiary established in 2020 to develop innovative learning methods in the biomedical field. It operates a professional training center offering courses, seminars, webinars, and auditor certification programs for pharma, medical device, advanced therapy, and medical cannabis industries.

gsap.co.il
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Gsap CRO was established in 2017 with experts from international CROs to help clients navigate Phase I and Phase II clinical trials. The CRO operates as a boutique CRO for clinical trial execution following ICH-GCP standards.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Life-science consulting firm specializing in quality assurance, validation, CSV, and regulatory affairs. Closely comparable to Gsap's engineering/validation and CSV service lines.

TypeBroad incumbent
Description

Global CRO and pre-clinical services provider. Overlaps with Gsap's pre-clinical and clinical research capabilities for biomedical clients.

TypeDirect peer
Description

European regulatory affairs consulting firm for pharma, biotech, and medical devices. Comparable to Gsap in regulatory strategy and submission services across multiple jurisdictions.

TypeDirect peer
Description

Clinical research and regulatory services provider spanning pharma, biologics, and medical devices. Comparable to Gsap's combined CRO and regulatory affairs service offering.

TypeBroad incumbent
Description

Major global CRO providing clinical research and consulting services across pharma and biotech. Overlaps with Gsap's CRO division and broader regulatory advisory work.

TypeBroad incumbent
Description

Largest global CRO and life-sciences consulting firm. Competes with Gsap for clinical trial and regulatory consulting work but operates at a vastly larger scale across all major geographies.

TypeDirect peer
Description

International regulatory, compliance, and clinical services consultancy for life sciences. Comparable to Gsap in providing multi-vertical regulatory and quality support to pharma and medtech clients.

TypeBroad incumbent
Description

Cloud software provider for life sciences including QMS, regulatory, and clinical platforms. Adjacent competitor to Gsap's Almond eQMS and CSV service lines, though at vastly larger scale.

TypeDirect peer
Description

Regulatory, compliance, and quality consulting firm serving pharma, medical device, and biotech clients. Directly comparable to Gsap in regulatory submissions, QMS implementation, and CSV/GxP IT services.

TypeDirect peer
Description

Global regulatory affairs and quality compliance consulting firm for pharma, biotech, and medical device companies. Highly comparable to Gsap across regulatory strategy, QMS setup, and GxP compliance service lines.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gsap

Biomedical Regulatory & Quality Consultinggsap.co.il

Gsap is an Israeli biomedical consulting firm providing regulatory affairs, quality assurance, CRO clinical research, engineering validation, and electronic QMS software to medical device, pharma, advanced therapy, digital health, medical cannabis, food tech, and hospital clients globally.

What Gsap does

Gsap is an Israeli professional services consulting firm headquartered in Haifa, founded in 2009, that provides end-to-end regulatory, quality, clinical, and engineering services to biomedical and life-science companies across seven industry verticals: medical devices, pharmaceuticals and biotechnology, advanced therapies (cell and gene), medical cannabis, digital health, food tech, and hospitals. The firm delivers regulatory strategy and submissions to FDA, EMA, and the Israeli Ministry of Health; quality management system setup and audit preparation; Contract Research Organization (CRO) services for Phase I-II clinical trials; engineering validation and qualification (IQ/OQ/PQ); and computerized systems validation (CSV). Core service lines are organized around recognized frameworks including GxP, GEP, GMP, ISO 13485, MDSAP, IEC 62304, ICH-GCP, and ISO 14155.

The business operates through four wholly-owned subsidiaries that extend its offering beyond consulting hours: SE-Pharma (GDP compliance and ISO/IEC 17025:2017 accredited laboratory services, est. 2016), Gsap CRO (boutique Phase I-II clinical trial management, est. 2017), Almond (electronic Quality Management System software platform, est. 2018), and G-Study (professional training, auditor certification, and the PractiClean conference, est. 2020). Revenue is generated through project-based professional services engagements, training course fees, and the Almond QMS software product, sold via direct consultative sales to enterprise clients including startups, pharma companies, hospitals, and medical device manufacturers. The firm employs approximately 60 staff at the parent plus 15 across subsidiaries, and reports cumulative engagement of 2,000+ projects, 300+ medical device clients (since 2014), and 40+ advanced therapy clients (since 2012), with notable customer engagements including Johnson & Johnson's Biosense Webster, Philips Haifa, Pluristem, Sheba Medical Center, Hadassah Medical Center, the Israel Institute for Biological Research (IIBR), and Syqe Medical.

Gsap is privately held with no external funding rounds disclosed and operates under a management-owned structure following the founding-era transition from founder Dr. Sigalit Ariely-Portnoy to current CEO Sharon Alon. Distribution is primarily direct enterprise sales complemented by content marketing, webinars, the PractiClean conference, and the Gstudy training platform, with geographic reach spanning the US, Europe (Germany, Netherlands), and the broader Israeli biomedical ecosystem.

Gsap firmographics

Firmographics
Name
Gsap
Legal name
Gsap
Website
https://gsap.co.il
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
51–100 employees
Short description
Gsap is an Israeli biomedical consulting firm providing regulatory affairs, quality assurance, CRO clinical research, engineering validation, and electronic QMS software to medical device, pharma, advanced therapy, digital health, medical cannabis, food tech, and hospital clients globally.
Ownership category
akta.pro rank

Gsap industry classification

Industry
Product category
Biomedical Regulatory & Quality Consulting
NAICS
Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAG
Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAOAK
CMC, Process Development & Tech Transfer Staffing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Regulatory affairs consulting
  • Quality assurance services
  • Biomedical consulting
  • GMP compliance consulting
  • Clinical research services

Where Gsap is headquartered

Location

Headquarters

HQ city
Haifa
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

Gsap business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Regulatory Affairs & Quality Consulting: Gsap charges fees for regulatory strategy, submissions (FDA, EMA, IMOH), quality management system setup, and compliance consulting. Revenue is project-based and varies by scope, typically structured as professional services engagements.
  2. CRO — Clinical Research Services: Full-service clinical trial management including study design, site management, monitoring, data management, biostatistics, and clinical study reports. Revenue is generated through project fees and service contracts following ICH-GCP standards.
  3. Gstudy — Professional Training Courses: Gsap operates Gstudy, a training center offering professional courses, seminars, auditor certification programs, and webinars. Revenue is generated through course fees.
  4. Engineering & Validation Services: Charges for engineering validation, qualification (IQ/OQ/PQ), facility design review, and GMP compliance services for pharmaceutical and medical device manufacturing facilities.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Gsap product offering

Product offering

Core offering

Gsap is a professional consulting firm providing end-to-end biomedical services spanning the entire product lifecycle — from concept to market — for pharmaceutical, medical device, advanced therapy, digital health, food tech, medical cannabis, and hospital clients. Core service lines include regulatory affairs (FDA, EMA, IMOH submissions), quality assurance and QMS setup, clinical research (CRO) trial management, engineering validation (GEP/GMP), computerized systems validation (CSV), pre-clinical studies, audit preparation, and grant writing. The firm supplements consulting with its Gstudy training academy and Almond electronic QMS platform, all delivered by 50+ expert consultants from its Haifa, Israel headquarters.

Product overview

Gsap is a comprehensive consulting and services firm for the biomedical industry, providing end-to-end services across the product lifecycle. The portfolio consists of core consulting service lines — Regulatory Affairs, Quality Assurance (QMS), Clinical Research (CRO), Engineering & Validation, Computerized System Validation (CSV), Pre-Clinical Studies, Grant & Technical Writing, and Audit Preparation — organized by specialized industry verticals: Pharmaceuticals, Medical Devices, Digital Health, Advanced Therapies (ATMP), FoodTech, Medical Cannabis, and Hospitals. The company operates two named sub-brands: Gsap CRO (a boutique CRO for clinical trial management under ICH-GCP) and Gstudy (a professional training and education center). Gsap's services are not packaged as a single software product but as professional consulting engagements delivered by domain experts.

Differentiator

Problem solved

Functional benefit

Brands

  • G-Study (Gstudy): Training and learning center offering professional courses, seminars, auditor certification, internal organizational training, online courses, and webinars for the pharma, advanced therapies, medical devices, and medical cannabis industries.
  • Gsap CRO
  • Almond
  • SE-Pharma

Products and services

  • Regulatory Affairs Consulting End-to-end regulatory strategy and submission services for biomedical products targeting FDA, EMA, Israeli Ministry of Health (IMOH/AMAR), Health Canada, and TGA, covering pre-IND/IND, NDA, BLA, MAA, 510(k), CE marking, and ATMP regulatory pathways for pharma, medical device, advanced therapy, digital health, food tech, and medical cannabis clients.
  • Quality Assurance (QMS) Consulting
  • Gsap CRO - Clinical Research Services Full-service Contract Research Organization providing clinical trial management from study design, regulatory submissions, site selection, monitoring, data management, biostatistics, and clinical study reports, following ISO 14155 and ICH-GCP standards for medical device, pharmaceutical, and advanced therapy trials.
  • Engineering & Validation Services
  • Computerized Systems Validation (CSV)
  • Pre-Clinical Studies
  • Audit Preparation & Inspection Support
  • Grant & Technical Writing
  • Gstudy - Professional Training Programs Professional training center offering courses, seminars, auditor certification programs, and webinars for pharma, medical device, advanced therapy, and medical cannabis industries. Courses are delivered both in-person at the Haifa training center and online in hybrid format; in-house corporate training programs are also available.
  • Almond - Electronic Quality Management System (QMS) Electronic Quality Management System (QMS) software platform (Almond II being the next-generation product) for biomedical companies, supporting document control, CAPA management, complaint handling, and quality process workflows.
  • SE-Pharma - GDP Compliance Services Good Distribution Practice (GDP) compliance consulting, Ministry of Health Procedure 126 implementation, and ISO/IEC 17025:2017 accredited laboratory services for pharmaceutical distributors and biomedical companies.

Quantifiable outcome

  • 2000+ projects completed across biomedical consulting portfolio
  • +5 more outcomes

Companies that use Gsap

Customer profile

Named customers13 records

Segments7 records

Ideal customer profiles6 records

Gsap technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Gsap partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • SE-PharmacoreOthersSE-Pharma is a wholly-owned subsidiary of Gsap, established in 2016 to support Gsap clients in implementing GDP requirements and Israeli Ministry of Health Procedure 126. The company is accredited to ISO/IEC 17025:2017 standards.
  • Almond (electronic QMS)coreOthersAlmond is a wholly-owned subsidiary of Gsap, established in 2018 to provide an electronic Quality Management System (QMS) at world-class level to biomedical companies in Israel and globally. Almond II represents the next-generation QMS platform.
  • G-StudycoreOthersG-Study is a wholly-owned subsidiary established in 2020 to develop innovative learning methods in the biomedical field. It operates a professional training center offering courses, seminars, webinars, and auditor certification programs for pharma, medical device, advanced therapy, and medical cannabis industries.
  • CRO Industry NetworkscoreStrategic or Co-development PartnerGsap CRO was established in 2017 with experts from international CROs to help clients navigate Phase I and Phase II clinical trials. The CRO operates as a boutique CRO for clinical trial execution following ICH-GCP standards.

Scale indicators9 records

Recent moves10 records

Expansion highlights6 records

Gsap competitors and assessment

Company assessment

Direct peers

  • QbD Group: Life-science consulting firm specializing in quality assurance, validation, CSV, and regulatory affairs. Closely comparable to Gsap's engineering/validation and CSV service lines.
  • BlueReg: European regulatory affairs consulting firm for pharma, biotech, and medical devices. Comparable to Gsap in regulatory strategy and submission services across multiple jurisdictions.
  • MakroCare: Clinical research and regulatory services provider spanning pharma, biologics, and medical devices. Comparable to Gsap's combined CRO and regulatory affairs service offering.
  • ProductLife Group: International regulatory, compliance, and clinical services consultancy for life sciences. Comparable to Gsap in providing multi-vertical regulatory and quality support to pharma and medtech clients.
  • ProPharma Group: Regulatory, compliance, and quality consulting firm serving pharma, medical device, and biotech clients. Directly comparable to Gsap in regulatory submissions, QMS implementation, and CSV/GxP IT services.
  • PharmaLex: Global regulatory affairs and quality compliance consulting firm for pharma, biotech, and medical device companies. Highly comparable to Gsap across regulatory strategy, QMS setup, and GxP compliance service lines.

Broad incumbents

  • Charles River Laboratories: Global CRO and pre-clinical services provider. Overlaps with Gsap's pre-clinical and clinical research capabilities for biomedical clients.
  • ICON plc: Major global CRO providing clinical research and consulting services across pharma and biotech. Overlaps with Gsap's CRO division and broader regulatory advisory work.
  • IQVIA: Largest global CRO and life-sciences consulting firm. Competes with Gsap for clinical trial and regulatory consulting work but operates at a vastly larger scale across all major geographies.
  • Veeva Systems: Cloud software provider for life sciences including QMS, regulatory, and clinical platforms. Adjacent competitor to Gsap's Almond eQMS and CSV service lines, though at vastly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Gsap social profiles

Digital presence

Gsap compliance and trust

Trust signal

Compliance6 records

Gsap financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gsap leadership team

Management profile

Number of profiles

Profiles9 records

Gsap subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Gsap funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gsap M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gsap

What does Gsap do?

Gsap is a professional consulting firm providing end-to-end biomedical services spanning the entire product lifecycle — from concept to market — for pharmaceutical, medical device, advanced therapy, digital health, food tech, medical cannabis, and hospital clients. Core service lines include regulatory affairs (FDA, EMA, IMOH submissions), quality assurance and QMS setup, clinical research (CRO) trial management, engineering validation (GEP/GMP), computerized systems validation (CSV), pre-clinical studies, audit preparation, and grant writing. The firm supplements consulting with its Gstudy training academy and Almond electronic QMS platform, all delivered by 50+ expert consultants from its Haifa, Israel headquarters.

Is Gsap a public or private company?

Gsap is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Gsap founded?

Gsap was founded in 2009. It employs 51 to 100 people.

Where is Gsap based?

Gsap is headquartered in Haifa, Israel, in the Middle East region.

How does Gsap make money?

Four revenue lines are on record. Regulatory Affairs & Quality Consulting is the primary driver. The others are CRO — Clinical Research Services, gstudy — Professional Training Courses and engineering & Validation Services.

Who are Gsap's main competitors?

Direct peers on record are QbD Group, BlueReg, MakroCare, ProductLife Group, ProPharma Group and PharmaLex. Broad incumbents are Charles River Laboratories, ICON plc, IQVIA and Veeva Systems.

Does Gsap have an API?

No public API is recorded for Gsap.

What industry is Gsap in?

Gsap's product category is Biomedical Regulatory & Quality Consulting. Its primary akta.pro industry code is HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight), with a secondary code of HLAGAKAG, Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11). Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GsapExtended Realities and Regulation : Extended Reality : GSAPExtended reality (XR) technologies like AR and VR are being adopted in healthcare for training, diagnostics, and therapy, with the market projected to reach $209 billion by 2022. The FDA and EU are updating regulations under the Software as Medical Device framework, including the Breakthrough Devices Program and a €9.2 billion EU investment. Cybersecurity and clinical evaluation remain key regulatory concerns.GsapCOVID-19: Latest news and analysis for the pharma industry : COVID-19 : GSAPThe newsletter reviews COVID-19 treatments, including FDA emergency authorizations for remdesivir and monoclonal antibodies, and Israeli drug trials. It reports Pfizer's vaccine efficacy of 95% and Israel's 53.7% vaccination rate. It also covers Johnson & Johnson's vaccine approval and new vaccine trials.GsapArticles Archives : GSAPGSAP provides multidisciplinary expertise across regulatory affairs, quality assurance, clinical research, engineering, and validation for healthcare and life sciences organizations. The company also offers professional training through GSAP Academy and expanded its services with the acquisition of HaMaDa, which strengthens expertise in medical devices, IVD, and digital health.GsapDigital Health Regulation: AI and Multiple Function Devices : GSAPThe FDA is proposing a framework for Good Machine Learning Practices and a predetermined change control plan for continuously learning AI/ML-based software as a medical device. It also issued guidance on multiple-function devices, requiring review if an unregulated function impacts the regulated one, such as sharing code or output screen.GsapVeklury:The First FDA Approved Drug for COVID-19 : GSAPThe FDA approved Veklury (remdesivir), the first COVID-19 treatment, on October 22, 2020. The drug shortened hospitalization from an average of 15 days to about 10 days. The approval followed a Fast Track designation and an earlier Emergency Use Authorization.GsapCRISPR Nobel Accelerate ATMP Development : GSAPThe Nobel Prize in Chemistry was awarded to Charpentier and Doudna for CRISPR/Cas9 gene editing. Gsap offers process development, preclinical, clinical, and regulatory services for gene-therapy products, including IND and BLA submissions.GsapMDR Gap Analysis – A Practical GSPR Gap Assessment : GSAPA practical guide outlines how to assess gaps between the MDD and MDR, covering technical documentation, GSPR, PMS, risk management, and biocompatibility. It lists specific MDR requirements, such as UDI, PRRC, and EUDAMED, and advises closing identified gaps. The guide also notes that biocompatibility testing not done and cannot be rationalized should be performed.GsapCOVID-19 IVD (In Vitro Diagnostics) : COVID-19 IVD : GSAPThe newsletter outlines emergency regulatory pathways for COVID-19 in vitro diagnostics, including FDA EUA, EU emergency market access, and Israel's AMAR temporary approval. It notes that most CE-marked rapid tests are compliant but some have fraudulent documentation, and GSAP supports companies in developing novel diagnostic solutions.